Home/Filings/4/0001209191-20-000767
4//SEC Filing

Jansen Burkhard 4

Accession 0001209191-20-000767

CIK 0001651944other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:04 PM ET

Size

8.7 KB

Accession

0001209191-20-000767

Insider Transaction Report

Form 4
Period: 2019-12-31
Jansen Burkhard
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-12-31$12.40/sh14,743$182,81371,165 total
  • Exercise/Conversion

    Common Stock

    2019-12-31+47,54185,908 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-3147,5410 total
    Common Stock (47,541 underlying)
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on December 31, 2019.

Issuer

DermTech, Inc.

CIK 0001651944

Entity typeother

Related Parties

1
  • filerCIK 0001787132

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:04 PM ET
Size
8.7 KB